You are here: Industry Insights > metformin

News List

Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation firstwordpharma
June 09, 2021
Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.
NPPA fixes retail prices of Vildagliptin 50 mg + Metformin Hydrochloride 500 mg and 1000 mg SR tablets expresspharma
February 18, 2021
It has decided to fix the retail price as per the Price To Retailer (PTR) based on Form-V data submitted by the companies for whom retail prices were earlier approved for these subject FDCs.
Metformin use reduces risk of death for patients with COVID-19 and diabetes worldpharmanews
January 19, 2021
Use of the diabetes drug metformin - before a diagnosis of COVID-19 - is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham ...
Study finds metformin reduced COVID-19 death risks in women worldpharmanews
December 07, 2020
University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients.
Micro Labs launches anti-diabetic drug combo, Dapagliflozin plus Metformin expresspharma
November 25, 2020
The drug comes in two strengths ZUCAPRIDE–M 500 priced at Rs12.80 per tablet and ZUCAPRIDE–M 1000 at Rs 14.80.
Aarti Drugs to expand metformin capacity to 3000 TPM expresspharma
November 02, 2020
Aarti Drugs has procured land to expand its existing Metformin Capacity to 3000 TPM in a brownfield expansion. This expansion would be a two-phase expansion program.
Marksans Pharma and Sun Pharma voluntarily recall metformin expresspharma
October 10, 2020
FDA publishes a recalled metformin list including details about metformin products that have been recalled.
Bayshore Voluntarily Recalls Extended Release Metformin americanpharmaceuticalreview
August 25, 2020
The U.S. Food and Drug Administration (FDA) is alerting patients and health care professionals to Bayshore Pharmaceuticals’ voluntary recall of two lots of extended release (ER) metformin (one lot of 750 mg tablets and one lot of 500 mg tablets).
Several Companies Voluntarily Recall Extended Release Metformin americanpharmaceuticalreview
July 15, 2020
The U.S. Food & Drug Administration (FDA) is alerting patients and health care professionals to several voluntary recalls of extended release (ER) metformin by the companies listed below.
FDA Updates and Press Announcements on NDMA in Metformin fda
July 08, 2020
Today, the AAPS Journal, an official journal of the American Association of Pharmaceutical Scientists, published FDA’s manuscript entitled, “A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metfor

Previous page 1 2 3 Next page